SEATTLE-Cell Therapeutics Inc., a biopharmaceutical company based in Seattle, is relocating its headquarters from 501 Elliott Ave. W to a larger space at 3101 Western Building. The company has signed a lease for roughly 66,000 square feet of space at the 187,000-square-foot building owned by Martin Selig.
Cell Therapeutics will occupy 6th, 7th and 8th floors of the 3101 Western Building. CBRE's Tim O'Keefe and Jesse Ottele represented the tenant in the lease transaction with Martin Selig Real Estate. For the full story, go to Puget Sound Business Journal .
GlobeSt.com News Hub is your link to relevant real estate and business stories from other local, regional and national publications.
© Arc, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to TMSalesOperations@arc-network.com. For more information visit Asset & Logo Licensing.